US$ 23.98
is saxenda a glp 1 drug (Liraglutide) GLP-1 analogues for medical weight
Description
is supported by operating grants from the CIHR, a Banting and Best Diabetes CentreNovo Nordisk Chair in Incretin Biology and a Sinai HealthNovo Nordisk Foundation Fund in Regulatory Peptides

Orskov C, Poulsen SS, Mller M, Holst JJ

Turton MD, O'Shea D, et al

Surprising fact: A study of 2 million Type 2 diabetes patients found that GLP-1 drug users had a lower risk of developing 42 different health conditions , including Alzheimers disease

Instead, clinicians should acknowledge this risk and consider individualized risk-benefit strategies when prescribing GLP-1 RAs, particularly for patients with pre-existing ocular manifestations and must inform patients regarding possible ocular hazards while advocating for regular retinal examinations and assessments of visual acuity

The HARMONY trial studied T2DM patients, 40 years and older, with established cardiovascular disease and reported that albiglutide reduced the primary composite outcome
